Russia Still Offers Vast Opportunities For India Drug Makers, Analysts Say
This article was originally published in PharmAsia News
Executive Summary
India drug makers may be taking a closer look at opportunities in Russia as the nation attempts to build a pharmaceutical sector capable of supplying its $6 billion Pharma2020 program.